Heart transplantation in mice has served as a reliable in vivo model in transplant research worldwide for more than half a century. It is not only useful for addressing cardiac graft-specific questions but also provides mechanistic insights and therapeutic strategies that have a broad impact across all solid organ transplants. Compared to other mouse models of solid organ transplantation, such as kidney, lung, or small intestine transplants, the surgical techniques to perform mouse heart transplantation (mHT) are relatively easy to master, and the graft heartbeat offers a simple means to evaluate transplant viability. However, as with other in vivo mouse models, mHT has distinct strengths and limitations. Multiple factors can influence the accuracy and reproducibility of the results, including microsurgical techniques and microsurgeons' skills, postoperative monitoring methodologies, mouse strain combinations, and sex/age. As innovative biotechnologies continue to emerge, the future holds many opportunities for preclinical research utilizing the mHT model. It is therefore imperative to provide the field with optimized mHT protocols and maintain standard reporting requirements. This minireview provided a concise summary and recommendations for standardized practices to ensure the accuracy, reproducibility, and translational value of findings generated from the mHT model.
Journal article
2025-09-01T00:00:00+00:00
25
1820 - 1829
9
CsA, MHC, acute cellular rejection, antibody-mediated rejection, chronic rejection, disparity, heart transplant, heart transplantation in mice, immunosuppression, ischemia-reperfusion injury, monotherapies, mouse, mycophenolate mofetil, rapamycin, rejection, tacrolimus, Heart Transplantation, Animals, Mice, Disease Models, Animal, Graft Survival, Practice Guidelines as Topic